Evidence map›Paper›PMID 40900987›Full record

ReviewSexual medicine2025

Clinical practice guidelines: sexual dysfunction in gynecological cancer patients.

Sharon Peleg Nesher, Mijal Luria, Gideon Sartorius, Francesca Tripodi, Michal Lew-Starowicz, Stephanie Both, Elisa Maseroli, Yacov Reisman, Giovanni Corona

Abstract readReview
In one paragraph

Review in Sexual medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sharon Peleg NesherDivision of Oncology, Tel Aviv Medical Center, Tel Aviv, 6423906, Israel.
Mijal LuriaRotem Center - The Israeli Center for Sex Therapy, Jerusalem, 9626935, Israel.ORCID https://orcid.org/0000-0003-4598-2864
Gideon SartoriusSexual Medicine, Women's Clinic, University Hospital Basel, Basel, 4031, Switzerland.
Francesca TripodiInstitute of Clinical Sexology, Rome, 00198, Italy.ORCID https://orcid.org/0000-0001-5680-6896
Michal Lew-StarowiczDepartment of Psychiatry Center of Postgraduate Medical Education, Warsaw, 23100416, Poland.
Stephanie BothDepartment of Sexology and Psychosomatic Gynecology and Obstetrics, Amsterdam UMC, Amsterdam, 1105 AZ, The Netherlands.
Elisa MaseroliAndrology and Gender Endocrinology Unit, Careggi University Hospital, Florence, 50139, Italy.
Yacov ReismanDepartment of Sexual Medicine, Flare-Health, Amsterdam, 1432BE, The Netherlands.ORCID https://orcid.org/0000-0002-1513-6360
Giovanni CoronaEndocrinology Unit, Azienda USL, Maggiore-Bellaria Hospital, Bologna, 40133, Italy.ORCID https://orcid.org/0000-0002-9894-2885

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Sexual dysfunctions (SDs) due to gynecological cancer (GC) are common. Healthcare providers (HCPs) are often not prepared to address sexual health issues, missing the opportunity to provide comprehensive post-cancer survivorship care. Aim: To review the available evidence about diagnosing and managing SD after GC and providing practical clinical suggestions on behalf of the European Society of Sexual Medicine. Methods: A systematic literature search was performed on Pubmed and Medline for the relevant literature from January 1980 until June 2024. Outcomes: Recommendations were provided according to the Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence criteria, focusing on clinical practice. Results: The main areas covered include the impact of diagnosis and treatment of GC (surgery, chemotherapy, immunotherapy, and radiotherapy) on sexual health; the process of screening, counseling, and referral; medical and psychological management of SD; issues related to special populations, ie, sexual minorities and previvors. Clinical Implications: Addressing aspects of sexual health is important in patients with GC during diagnosis, treatment, and post-cancer care. Diagnosis and treatment of SDs should follow the recommendations in non-cancer patients, but specific aspects linked to cancer and its treatment should be kept in mind. Strengths and Limitations: All studies have been evaluated by a panel of experts who provide comprehensive, evidence-based recommendations for clinical practice. Conclusion: HCPs should feel comfortable addressing sexual health topics in patients with GCs due to the abundance of available data. Appropriate sexological interventions can improve the quality of life for patients and their partners.

Indexed as

cancer caregynecological canceroncosexologysexual dysfunctionsexual health

Identifiers

PMID40900987
PMCPMC12401004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.